Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Terzolo, M., Fassnacht, M., Perotti, P., Libe, R., Kaštelan, D., Lacroix, A. ... Berruti, A. (2023). Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study. The Lancet Diabetes & Endocrinology, 11. (10), 720-730. doi: 10.1016/S2213-8587(23)00193-6
Terzolo, Massimo, et al. "Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study." The Lancet Diabetes & Endocrinology, vol. 11, no. 10, 2023, pp. 720-730. https://doi.org/10.1016/S2213-8587(23)00193-6
Terzolo, Massimo, Martin Fassnacht, Paola Perotti, Rossella Libe, Darko Kaštelan, Andre Lacroix, Wiebke Arlt, et al. "Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study." The Lancet Diabetes & Endocrinology 11, no. 10 (2023): 720-730. https://doi.org/10.1016/S2213-8587(23)00193-6
Terzolo, M., et al. (2023) 'Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study', The Lancet Diabetes & Endocrinology, 11(10), pp. 720-730. doi: 10.1016/S2213-8587(23)00193-6
Terzolo M, Fassnacht M, Perotti P, Libe R, Kaštelan D, Lacroix A, and sur.. Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study. The Lancet Diabetes & Endocrinology [Internet]. 2023 October [cited 2024 October 07];11(10):720-730. doi: 10.1016/S2213-8587(23)00193-6
M. Terzolo, et al., "Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study", The Lancet Diabetes & Endocrinology, vol. 11, no. 10, pp. 720-730, October 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:260017. [Accessed: 07 October 2024]